Assessing the risk of dolutegravir for women of childbearing potential

Lancet Glob Health. 2018 Sep;6(9):e958-e959. doi: 10.1016/S2214-109X(18)30326-7. Epub 2018 Jul 23.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Retroviral Agents / adverse effects*
  • Botswana / epidemiology
  • Female
  • HIV Infections / drug therapy*
  • Heterocyclic Compounds, 3-Ring / adverse effects*
  • Humans
  • Infant, Newborn
  • Neural Tube Defects / epidemiology
  • Oxazines
  • Piperazines
  • Pregnancy
  • Pyridones
  • Risk Assessment

Substances

  • Anti-Retroviral Agents
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir